We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp

Delisted

NYMX was delisted on the 6th of July, 2023.

43 hedge funds and large institutions have $2.05M invested in Nymox Pharmaceutical Corp in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

13% more funds holding

Funds holding: 3843 (+5)

0% more call options, than puts

Call options by funds: $12K | Put options by funds: $12K

49% less capital invested

Capital invested by funds: $4M → $2.05M (-$1.95M)

72% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 18

Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
5
Reduced
18
Closed
4
Calls
$12K
Puts
$12K
Net Calls
Net Calls Change
-$36K
Name Holding Trade Value Shares
Change
Change in
Stake
FTDI
26
First Trust Direct Indexing
Massachusetts
$15K +$18.1K +11,315 New
ODIJL
27
One Day In July LLC
Vermont
$13K
Optiver Holding
28
Optiver Holding
Netherlands
$13K
LNC
29
Lincoln National Corp
Pennsylvania
$13K +$16.5K +10,315 New
TRCT
30
Tower Research Capital (TRC)
New York
$11K +$13.4K +8,417 New
Osaic Holdings
31
Osaic Holdings
Arizona
$10K -$6.54K -4,100 -34%
Wells Fargo
32
Wells Fargo
California
$10K
PA
33
PSI Advisors
Florida
$10K +$7.98K +5,000 +167%
CA
34
Cornerstone Advisory
Maryland
$6K +$7.24K +4,536 New
SIAP
35
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$3K
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$2.21K +$5 +3 +0.2%
Rockefeller Capital Management
37
Rockefeller Capital Management
New York
$2K
Group One Trading
38
Group One Trading
Illinois
$1K -$34.2K -21,433 -97%
UBS Group
39
UBS Group
Switzerland
$1K -$4.44K -2,783 -83%
HF
40
HRT Financial
New York
-$236K -114,635 Closed
Brown Advisory
41
Brown Advisory
Maryland
-$39K -18,700 Closed
Barclays
42
Barclays
United Kingdom
-$10K -5,046 Closed
NFSG
43
Newbridge Financial Services Group
Florida
-$5K -2,500 Closed
SFG
44
Steward Financial Group
Texas
+$160 +100 New
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
+$319 +200 New
SCA
46
Snowden Capital Advisors
New York
+$1.08K +675 New

NYMX Hedge Fund Activity: Q4 2021 in Review

43 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2021, worth a combined $2.05M — down 49% from $4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NYMX positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 18 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $40.9K. The largest seller was HRT Financial, exiting entirely with an estimated $236K sold.

  • 43 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $2.05M of Nymox Pharmaceutical Corp stock for Q4 2021, down 49% quarter-over-quarter.
  • 9 funds opened new Nymox Pharmaceutical Corp positions in Q4 2021 and 4 closed out, a net change of +5 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q4 2021 was Jane Street, an estimated $40.9K added.
  • The largest Nymox Pharmaceutical Corp seller in Q4 2021 was HRT Financial, an estimated $236K sold.

Based on aggregated 13F filings for Q4 2021.